Abstract
Several studies have shown the correlation between RANTES gene and inflammatory disorders; the aim of the present study was to investigate the association between RANTES promoter gene polymorphism and Meniere’s disease (MD) in an Iranian population. In this study patients with MD comprising definite MD (N = 56) and probable MD (N = 15) were selected according to diagnostic criteria of AAO-HNS. The control group (N = 101) were healthy normal subjects who did not have a history of ear disease and vertigo. PCR–RFLP for RANTES −403G>A has been performed. We found a protective role for RANTES −403A allele in male group in our population. None of the male patients with MD were carrier of allele A which was significantly different from the presence of allele A in the male control group (AA+GA vs. GG: p = 0.0004, OR 0.05, 95 % CI 0.001–0.39). This difference was not significant in female group. There was no significant association between RANTES gene polymorphism and the level of hearing loss. our results showed a sex-specific association between RANTES gene polymorphism and MD but more studies are necessary to further assess this association.
Similar content being viewed by others
References
An P et al (2002) Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 99(15):10002–10007
McDermott DH et al (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14(17):2671–2678
Nickel RG et al (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the c-c chemokine RANTES. J Immunol 164(3):1612–1616
Maghazachi AA, Al-Aoukaty A, Schall TJ (1996) CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol 26(2):315–319
Loetscher P et al (1996) Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 156(1):322–327
Kameyoshi Y et al (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176(2):587–592
Mattoli S et al (1995) Mast cell chemotactic activity of RANTES. Biochem Biophys Res Commun 209(1):316–321
Fine JS et al (2001) Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis. Inflammation 25(2):61–67
Cross AK, Woodroofe MN (1999) Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J Neurosci Res 55(1):17–23
Appay V, Rowland-Jones SL (2001) RANTES: a versatile and controversial chemokine. Trends Immunol 22(2):83–87
Tavakkoly-Bazzaz J et al (2011) RANTES gene mRNA expression and its −403 G/A promoter polymorphism in coronary artery disease. Gene 487(1):103–106
Amoli MM et al (2009) Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum. Clin Exp Rheumatol 27(1 Suppl 52):S142–S143
Fung K et al (2002) Genetic basis of familial Meniere’s disease. J Otolaryngol 31(1):1–4
Wassef M (2009) Pathology of the ear. Ann Pathol 29(4):347–360
da Costa SS, de Sousa LC, Piza MR (2002) Meniere’s disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am 35(3):455–495
Mancini F et al (2002) History of Meniere’s disease and its clinical presentation. Otolaryngol Clin North Am 35(3):565–580
Pulec, J.L., Meniere’s disease of syphilitic etiology. Ear Nose Throat J, 1997. 76(8): p. 508-10, 512 514, passim
Hajeer AH (1999) F. al Sharif, and W.E. Ollier, A polymorphism at position −403 in the human RANTES promoter. Eur J Immunogenet 26(5):375–376
Morrison AW et al (1994) On genetic and environmental factors in Meniere’s disease. Am J Otol 15(1):35–39
Klar J et al (2006) A Meniere’s disease gene linked to chromosome 12p12.3. Am J Med Genet B Neuropsychiatr Genet 141B(5):463–467
Berlinger NT (2011) Meniere’s disease: new concepts, new treatments. Minn Med 94(11):33–36
Navratilova Z (2006) Polymorphisms in CCL2&CCL5 chemokines/chemokine receptors genes and their association with diseases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(2):191–204
Fryer AA et al (2000) The −403G>A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 1(8):509–514
Schall TJ et al (1990) Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347(6294):669–671
Sorensen TL et al (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103(6):807–815
Snowden N et al (1994) RANTES role in rheumatoid arthritis. Lancet 343(8896):547–548
Takada T et al (2001) Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 58(5):293–298
Simeoni E et al (2004) Association of RANTES G−1alpha: impact on403A gene polymorphism with increased risk of coronary arteriosclerosis. Eur Heart J 25(16):1438–1446
Weyrich AS, Prescott SM, Zimmerman GA (2002) Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation 106(12):1433–1435
Lindemann S et al (2001) Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 154(3):485–490
von Hundelshausen P et al (2001) RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103(13):1772–1777
Makki RF et al (2000) RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Clin Exp Rheumatol 18(3):391–393
Mlynarski WM et al (2005) Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes 54(11):3331–3335
Chen Y et al (2004) Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 63(1):41–45
Laplana M, Fibla J (2012) Distribution of functional polymorphic variants of inflammation-related genes RANTES and CCR5 in long-lived individuals. Cytokine 58(1):10–13
Eskes T, Haanen C (2007) Why do women live longer than men? Eur J Obstet Gynecol Reprod Biol 133(2):126–133
Yang Y, Kozloski M (2011) Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci 66(5):493–500
Gonzalez E et al (2001) Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A 98(9):5199–5204
Liu H et al (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96(8):4581–4585
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazdani, N., Mojbafan, M., Taleba, M. et al. Sex-specific association of RANTES gene −403 variant in Meniere’s disease. Eur Arch Otorhinolaryngol 272, 2221–2225 (2015). https://doi.org/10.1007/s00405-014-3151-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3151-y